These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27349232)

  • 1. The neurotoxicity of iron, copper and cobalt in Parkinson's disease through ROS-mediated mechanisms.
    Lan AP; Chen J; Chai ZF; Hu Y
    Biometals; 2016 Aug; 29(4):665-78. PubMed ID: 27349232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
    Guo JD; Zhao X; Li Y; Li GR; Liu XL
    Int J Mol Med; 2018 Apr; 41(4):1817-1825. PubMed ID: 29393357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Manganese, Zinc, and Copper Metal Toxicity on SH-SY5Y Cells in Establishing an Idiopathic Parkinson's Disease Model.
    Pradhan SH; Liu JY; Sayes CM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification.
    Bjørklund G; Hofer T; Nurchi VM; Aaseth J
    J Inorg Biochem; 2019 Oct; 199():110717. PubMed ID: 31369907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models.
    Ohiomokhare S; Olaolorun F; Ladagu A; Olopade F; Howes MR; Okello E; Olopade J; Chazot PL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease.
    Zhao J; Yu S; Zheng Y; Yang H; Zhang J
    Mol Neurobiol; 2017 Mar; 54(2):1404-1418. PubMed ID: 26843115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.
    Valko M; Jomova K; Rhodes CJ; Kuča K; Musílek K
    Arch Toxicol; 2016 Jan; 90(1):1-37. PubMed ID: 26343967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-induced hepatotoxicity.
    Britton RS
    Semin Liver Dis; 1996 Feb; 16(1):3-12. PubMed ID: 8723319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
    Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M
    Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired iron homeostasis in Parkinson's disease.
    Double KL; Gerlach M; Youdim MB; Riederer P
    J Neural Transm Suppl; 2000; (60):37-58. PubMed ID: 11205155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heavy-metal-induced reactive oxygen species: phytotoxicity and physicochemical changes in plants.
    Shahid M; Pourrut B; Dumat C; Nadeem M; Aslam M; Pinelli E
    Rev Environ Contam Toxicol; 2014; 232():1-44. PubMed ID: 24984833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in metal-induced oxidative stress and human disease.
    Jomova K; Valko M
    Toxicology; 2011 May; 283(2-3):65-87. PubMed ID: 21414382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.
    Drechsel DA; Patel M
    Free Radic Biol Med; 2008 Jun; 44(11):1873-86. PubMed ID: 18342017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson's Disease.
    Gonzalez-Alcocer A; Duarte-Jurado AP; Soto-Dominguez A; Loera-Arias MJ; Villarreal-Silva EE; Saucedo-Cardenas O; de Oca-Luna RM; Garcia-Garcia A; Rodriguez-Rocha H
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.
    Yokoyama H; Kuroiwa H; Yano R; Araki T
    Neurol Sci; 2008 Oct; 29(5):293-301. PubMed ID: 18941931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.